These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 27826287)

  • 21. PARP1 Stabilizes CTCF Binding and Chromatin Structure To Maintain Epstein-Barr Virus Latency Type.
    Lupey-Green LN; Caruso LB; Madzo J; Martin KA; Tan Y; Hulse M; Tempera I
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29976663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Genome-Wide Epstein-Barr Virus Polyadenylation Map and Its Antisense RNA to EBNA.
    Majerciak V; Yang W; Zheng J; Zhu J; Zheng ZM
    J Virol; 2019 Jan; 93(2):. PubMed ID: 30355690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
    Leong IT; Fernandes BJ; Mock D
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative multi-target RNA profiling in Epstein-Barr virus infected tumor cells.
    Greijer AE; Ramayanti O; Verkuijlen SA; Novalić Z; Juwana H; Middeldorp JM
    J Virol Methods; 2017 Mar; 241():24-33. PubMed ID: 27993616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epstein-Barr Virus Oncoprotein LMP1 Mediates Epigenetic Changes in Host Gene Expression through PARP1.
    Martin KA; Lupey LN; Tempera I
    J Virol; 2016 Oct; 90(19):8520-30. PubMed ID: 27440880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RNA Sequencing Analyses of Gene Expression during Epstein-Barr Virus Infection of Primary B Lymphocytes.
    Wang C; Li D; Zhang L; Jiang S; Liang J; Narita Y; Hou I; Zhong Q; Zheng Z; Xiao H; Gewurz BE; Teng M; Zhao B
    J Virol; 2019 Jul; 93(13):. PubMed ID: 31019051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Valpromide Inhibits Lytic Cycle Reactivation of Epstein-Barr Virus.
    Gorres KL; Daigle D; Mohanram S; McInerney GE; Lyons DE; Miller G
    mBio; 2016 Mar; 7(2):e00113. PubMed ID: 26933051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interferon-γ-inducible protein 16 (IFI16) is required for the maintenance of Epstein-Barr virus latency.
    Pisano G; Roy A; Ahmed Ansari M; Kumar B; Chikoti L; Chandran B
    Virol J; 2017 Nov; 14(1):221. PubMed ID: 29132393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epstein-Barr Virus (EBV) Latent Protein EBNA3A Directly Targets and Silences the
    Bazot Q; Paschos K; Allday MJ
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29367247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epstein-Barr Virus Induces Adhesion Receptor CD226 (DNAM-1) Expression during Primary B-Cell Transformation into Lymphoblastoid Cell Lines.
    Grossman L; Chang C; Dai J; Nikitin PA; Jima DD; Dave SS; Luftig MA
    mSphere; 2017; 2(6):. PubMed ID: 29202043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of ARKL1 as a Negative Regulator of Epstein-Barr Virus Reactivation.
    Siddiqi UZ; Vaidya AS; Li X; Marcon E; Tsao SW; Greenblatt J; Frappier L
    J Virol; 2019 Oct; 93(20):. PubMed ID: 31341047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. B Cell-Specific Transcription Activator PAX5 Recruits p300 To Support EBNA1-Driven Transcription.
    Liu CD; Lee HL; Peng CW
    J Virol; 2020 Mar; 94(7):. PubMed ID: 31941781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rta of murine gammaherpesvirus 68 reactivates the complete lytic cycle from latency.
    Wu TT; Usherwood EJ; Stewart JP; Nash AA; Sun R
    J Virol; 2000 Apr; 74(8):3659-67. PubMed ID: 10729142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-18a reactivates the Epstein-Barr virus through defective DNA damage response and promotes genomic instability in EBV-associated lymphomas.
    Cao P; Zhang M; Wang L; Sai B; Tang J; Luo Z; Shuai C; Zhang L; Li Z; Wang Y; Li G; Xiang J
    BMC Cancer; 2018 Dec; 18(1):1293. PubMed ID: 30594162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of Epstein-Barr Virus Lytic Reactivation by the Atypical Antipsychotic Drug Clozapine.
    Anderson AG; Gaffy CB; Weseli JR; Gorres KL
    Viruses; 2019 May; 11(5):. PubMed ID: 31108875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Latent and lytic Epstein-Barr virus replication strategies.
    Tsurumi T; Fujita M; Kudoh A
    Rev Med Virol; 2005; 15(1):3-15. PubMed ID: 15386591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Screen for Epstein-Barr Virus Proteins That Inhibit the DNA Damage Response Reveals a Novel Histone Binding Protein.
    Ho TH; Sitz J; Shen Q; Leblanc-Lacroix A; Campos EI; Borozan I; Marcon E; Greenblatt J; Fradet-Turcotte A; Jin DY; Frappier L
    J Virol; 2018 Jul; 92(14):. PubMed ID: 29743367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes.
    Rowe M; Lear AL; Croom-Carter D; Davies AH; Rickinson AB
    J Virol; 1992 Jan; 66(1):122-31. PubMed ID: 1309242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EBV-Encoded Latent Genes.
    Kanda T
    Adv Exp Med Biol; 2018; 1045():377-394. PubMed ID: 29896676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epstein-Barr virus (EBV) reactivation and therapeutic inhibitors.
    Kerr JR
    J Clin Pathol; 2019 Oct; 72(10):651-658. PubMed ID: 31315893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.